Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0045 | 0.9 |